Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenus
3,744,218
3,671,328
3,558,732
3,360,008
3,290,921
3,211,125
Croissance des revenus (H/H)
4%
3%
6%
2%
2%
-1%
Coût des ventes
3,484,621
3,415,569
3,312,077
3,135,703
3,073,476
2,996,912
Bénéfice brut
259,597
255,759
246,655
224,305
217,445
214,213
Vente, Général et Administration
192,562
185,216
184,686
163,040
159,379
162,802
Recherche et développement
--
1,418
991
103
108
106
Frais d'exploitation
206,067
200,150
199,325
175,333
171,821
175,637
Autres revenus (charges) non opérationnels
10,729
10,845
11,448
9,959
10,246
9,158
Bénéfice avant impôts
76,769
76,734
74,741
70,061
57,284
49,237
Charge d'impôt sur le revenu
25,323
25,203
22,973
21,738
18,087
15,621
Bénéfice net
40,642
40,279
41,474
38,806
29,423
23,926
Croissance du bénéfice net
-12%
-3%
7%
32%
23%
-37%
Actions en circulation (diluées)
206.04
208.49
211.78
216.34
223.12
223.06
Variation des actions (H-H)
-1%
-2%
-2%
-3%
0%
-3%
EPS (dilué)
197.24
193.19
195.83
179.37
131.86
107.26
Croissance du EPS
-11%
-1%
9%
36%
23%
-35%
Flux de trésorerie libre
34,134
48,128
48,192
2,642
42,340
18,780
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
6.93%
6.96%
6.93%
6.67%
6.6%
6.67%
Marge opérationnelle
1.42%
1.51%
1.32%
1.45%
1.38%
1.2%
Marge bénéficiaire
1.08%
1.09%
1.16%
1.15%
0.89%
0.74%
Marge du flux de trésorerie libre
0.91%
1.31%
1.35%
0.07%
1.28%
0.58%
EBITDA
67,034
69,123
60,977
61,160
57,957
51,351
Marge EBITDA
1.79%
1.88%
1.71%
1.82%
1.76%
1.59%
D&A pour le résultat opérationnel
13,504
13,514
13,647
12,188
12,333
12,775
EBIT
53,530
55,609
47,330
48,972
45,624
38,576
Marge EBIT
1.42%
1.51%
1.32%
1.45%
1.38%
1.2%
Taux d'imposition effectif
32.98%
32.84%
30.73%
31.02%
31.57%
31.72%
Statistiques clés
Clôture préc.
$19
Prix d'ouverture
$19
Plage de la journée
$19 - $19
Plage de 52 semaines
$13.48 - $19
Volume
200
Volume moyen
65
BPA (TTM)
1.24
Rendement en dividend
--
Capitalisation boursière
$3.8B
Qu’est-ce que MEDIPAL HOLDINGS CORP ?
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 13,061 full-time employees. The firm operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The firm also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.